BCRX - BioCryst spikes after a series of insider purchases
2024-05-15 10:12:07 ET
More on BioCryst Pharmaceuticals
- BioCryst: Estimate-Beating Q1 But Risks Are Considerable
- BioCryst Pharmaceuticals, Inc. (BCRX) Q1 2024 Earnings Call Transcript
- BioCryst Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation
- BioCryst surges 18% on quarterly earnings, adjusted guidance outlook
- BioCryst Pharmaceuticals beats top-line and bottom-line estimates; updates FY24 outlook